| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.006 |